Smartleaf Asset Management
UTMD icon

Smartleaf Asset Management’s Utah Medical Products UTMD Stock Holding History

Smartleaf Asset Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$750 Buy
+10
New +$713 ﹤0.01% 3266
2025
Q1 		– Sell
-5
Closed -$304 – 3010
2024
Q4 		$304 Hold
5
– – ﹤0.01% 2838
2024
Q3 		$333 Buy
+5
New +$339 ﹤0.01% 2833

Other funds holding UTMD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Cardinal Capital Management Inc (North Carolina)
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Smartleaf Asset Management's UTMD Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Utah Medical Products (UTMD) in Q3 2026: 10 shares worth $750. The stake represents ﹤0.01% of the portfolio and ranks #3266 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in UTMD as recently as Q4 2024.

Smartleaf Asset Management first reported a position in UTMD in Q3 2024 and has held it in 3 quarters since. 59 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

  • Smartleaf Asset Management held 10 shares of Utah Medical Products worth $750 as of Q3 2026.
  • Utah Medical Products was a new Smartleaf Asset Management position in Q3 2026.
  • Utah Medical Products made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3266 holding.
  • Smartleaf Asset Management first reported a position in Utah Medical Products in Q3 2024 and has held it in 3 quarters since.
  • 59 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.